Market Overview:
The global bullous pemphigoid treatment market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of bullous pemphigoid, rising awareness about the disease, and technological advancements in the field of bullous pemphigoid treatment. The global bullous pemphigoid treatment market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into immunosuppressant medication, steroids, antibiotics & antiseptics, and pain relief medication. Immunosuppressant medications are expected to dominate this market during the forecast period owing to their high efficacy in treating bullous pemphigoid. On the basis of application, it is segmented into hospitals pharmacies, retail pharmacies mail order pharmacies).
Product Definition:
Bullous pemphigoid is a rare autoimmune skin disorder that most often affects adults older than 60. The condition causes blisters to form on the skin. These blisters can be large and painful. Treatment for bullous pemphigoid includes medications to suppress the immune system, such as prednisone, and antibiotics to treat any infections that may occur.
Immunosuppressant Medication:
Immunosuppressant medication is used to reduce the immune response to a particular drug or antigen. It does this by decreasing or suppressing the production of certain chemicals called cytokines by the immune system. The main goal of these medications is to allow patients' bodies to heal from diseases and infections faster without interference from harmful inflammation responses.
Steroids:
Steroids are man-made body chemicals that are extracted from animal or plant sources and used to increase the strength of an individual. They can be administered as pharmaceutical drugs, in the form of dietary supplements, or through injections. Steroids can have side effects on the human body such as acne, increased facial hair, deepened voice & grow Pubic Hair (Hair Growth).
Application Insights:
The others segment dominated the global bullous pemphigoid treatment market in 2017, accounting for over 50.0% share of the overall revenue. The application segment is further divided into hospitals, pharmacies and mail order pharmacies. Hospitals are expected to be at a forefront of adopting new technologies and medicines especially when it comes to treating life-threatening diseases due to advanced medical facilities and highly skilled medical staff available in these institutions. This factor is anticipated to fuel bullous pemphigoid treatment demand in hospital settings during the forecast period across regions globally.
Regional Analysis:
North America accounted for the largest share of the global market in 2017. The presence of key players, favorable reimbursement scenario, and high adoption rate for new treatment methods are some factors responsible for its dominance. Moreover, increasing incidence of bullous pemphigoid is also one factor contributing to its growth. According to a study published by National Institute of Health (NIH), around 9500 cases were reported in U.S from 2012 to 2016 which indicates an increase in incidence over previous years as well as other countries where this condition is found commonly (Europe & Asia).
Asia Pacific region is expected to witness lucrative growth during the forecast period owing to rising healthcare expenditure and improving healthcare infrastructure especially in developing economies such as India and China.
Growth Factors:
- Increasing incidence of bullous pemphigoid
- Growing awareness about the disease and its treatment options
- Rising demand for better and more effective therapies for bullous pemphigoid
- Availability of novel treatments that are safe and effective
- Growing number of clinical studies on new therapies for bullous pemphigoid
Scope Of The Report
Report Attributes
Report Details
Report Title
Bullous Pemphigoid Treatment Market Research Report
By Type
Immunosuppressant Medication, Steroids, Antibiotics & Antiseptics, Pain Relief Medication
By Application
Hospitals Pharmacies, Retail Pharmacies, Mail Order Pharmacies
By Companies
Pfizer, Aqua Pharmaceuticals, Sirius Laboratories, DUBLIN Pharmaceuticals, Teva Pharmaceuticals, Astellas Pharma, Aegis Pharmaceuticals, Sun Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Bullous Pemphigoid Treatment Market Report Segments:
The global Bullous Pemphigoid Treatment market is segmented on the basis of:
Types
Immunosuppressant Medication, Steroids, Antibiotics & Antiseptics, Pain Relief Medication
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals Pharmacies, Retail Pharmacies, Mail Order Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Aqua Pharmaceuticals
- Sirius Laboratories
- DUBLIN Pharmaceuticals
- Teva Pharmaceuticals
- Astellas Pharma
- Aegis Pharmaceuticals
- Sun Pharmaceuticals
Highlights of The Bullous Pemphigoid Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunosuppressant Medication
- Steroids
- Antibiotics & Antiseptics
- Pain Relief Medication
- By Application:
- Hospitals Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bullous Pemphigoid Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bullous Pemphigoid Treatment is a combination of medications and treatments that are used to treat bullous pemphigoid. These treatments may include topical corticosteroids, immunosuppressants, and anticonvulsants.
Some of the major companies in the bullous pemphigoid treatment market are Pfizer, Aqua Pharmaceuticals, Sirius Laboratories, DUBLIN Pharmaceuticals, Teva Pharmaceuticals, Astellas Pharma, Aegis Pharmaceuticals, Sun Pharmaceuticals.
The bullous pemphigoid treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bullous Pemphigoid Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bullous Pemphigoid Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bullous Pemphigoid Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bullous Pemphigoid Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bullous Pemphigoid Treatment Market Size & Forecast, 2018-2028
4.5.1 Bullous Pemphigoid Treatment Market Size and Y-o-Y Growth
4.5.2 Bullous Pemphigoid Treatment Market Absolute $ Opportunity
Chapter 5 Global Bullous Pemphigoid Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bullous Pemphigoid Treatment Market Size Forecast by Type
5.2.1 Immunosuppressant Medication
5.2.2 Steroids
5.2.3 Antibiotics & Antiseptics
5.2.4 Pain Relief Medication
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bullous Pemphigoid Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bullous Pemphigoid Treatment Market Size Forecast by Applications
6.2.1 Hospitals Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Mail Order Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bullous Pemphigoid Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bullous Pemphigoid Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bullous Pemphigoid Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Bullous Pemphigoid Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bullous Pemphigoid Treatment Market Size Forecast by Type
9.6.1 Immunosuppressant Medication
9.6.2 Steroids
9.6.3 Antibiotics & Antiseptics
9.6.4 Pain Relief Medication
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bullous Pemphigoid Treatment Market Size Forecast by Applications
9.10.1 Hospitals Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Mail Order Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bullous Pemphigoid Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Bullous Pemphigoid Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bullous Pemphigoid Treatment Market Size Forecast by Type
10.6.1 Immunosuppressant Medication
10.6.2 Steroids
10.6.3 Antibiotics & Antiseptics
10.6.4 Pain Relief Medication
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bullous Pemphigoid Treatment Market Size Forecast by Applications
10.10.1 Hospitals Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Mail Order Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bullous Pemphigoid Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bullous Pemphigoid Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bullous Pemphigoid Treatment Market Size Forecast by Type
11.6.1 Immunosuppressant Medication
11.6.2 Steroids
11.6.3 Antibiotics & Antiseptics
11.6.4 Pain Relief Medication
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bullous Pemphigoid Treatment Market Size Forecast by Applications
11.10.1 Hospitals Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Mail Order Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bullous Pemphigoid Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Bullous Pemphigoid Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bullous Pemphigoid Treatment Market Size Forecast by Type
12.6.1 Immunosuppressant Medication
12.6.2 Steroids
12.6.3 Antibiotics & Antiseptics
12.6.4 Pain Relief Medication
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bullous Pemphigoid Treatment Market Size Forecast by Applications
12.10.1 Hospitals Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Mail Order Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bullous Pemphigoid Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bullous Pemphigoid Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bullous Pemphigoid Treatment Market Size Forecast by Type
13.6.1 Immunosuppressant Medication
13.6.2 Steroids
13.6.3 Antibiotics & Antiseptics
13.6.4 Pain Relief Medication
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bullous Pemphigoid Treatment Market Size Forecast by Applications
13.10.1 Hospitals Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Mail Order Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bullous Pemphigoid Treatment Market: Competitive Dashboard
14.2 Global Bullous Pemphigoid Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Aqua Pharmaceuticals
14.3.3 Sirius Laboratories
14.3.4 DUBLIN Pharmaceuticals
14.3.5 Teva Pharmaceuticals
14.3.6 Astellas Pharma
14.3.7 Aegis Pharmaceuticals
14.3.8 Sun Pharmaceuticals
